China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.

A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological conditions such as epilepsy, spinal cord injury, ALS, stroke, and ...

China’s remarkable advancements in brain-computer interface (BCI) technology are setting the stage for the nation to shift the balance in AI and human thought. We are heading into a time when you ...

Looser regulation and new investment are helping groups such as NeuroXess accelerate trials of ‘brain-computer interfaces’ ...

Brain-Computer Interfaces (BCIs) are emerging as transformative tools that enable direct communication between the human brain and external devices. With recent advancements in Electroencephalography ...

An important milestone for brain-computer interfaces has been achieved. A new peer-reviewed neuroscience study led by researchers at the University of California, Los Angeles (UCLA) demonstrates a ...

Brain–computer interfaces are beginning to truly "understand" Chinese. The INSIDE Institute for NeuroAI, in collaboration with Huashan Hospital affiliated with Fudan University, the National Center ...

OpenAI is continuing its push into healthcare by investing in Merge Labs, a brain-computer interface startup co-founded by its CEO, Sam Altman. Merge Labs is a new competitor to Elon Musk’s Neuralink, ...

MIT researchers have created subcellular ‘circulatronic’ brain implants that can be administered via injection and self-implant to target a variety of ailments directly.

Fabricated as a single chip, the new implant is orders of magnitude faster and smaller than today’s state-of-the-art brain-computer interfaces, offering an opportunity for more efficacious treatment ...